Abstract
Objectives
To estimate direct and indirect costs of care of type 2 diabetes (T2DM) and its complications in Argentina, and compare them with those recorded in people without diabetes (ND).
Methods
Observational retrospective case–control study performed in one institution of the Social Security System of Argentina. Participants were identified and randomly selected from the Institution’s electronic medical records. We recruited persons with T2DM with (387) or without (387) chronic complications and 774 ND, matched by age and gender. Data were obtained by telephone interviews and supplemented with data from the Institution’s records. Parametric and non-parametric tests were used for group comparisons.
Results
Direct costs were higher in people with T2DM than in ND: twice as high in people with T2DM without complications and 3.6 times in those with complications. Absenteeism was only higher in T2DM with complications, but there were no differences among groups either in the duration or in the cost of such absenteeism.
Conclusions
T2DM and the development of its complications are positively associated with higher direct costs in Argentina.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alexander GC, Sehgal NL, Moloney RM, Stafford RS (2008) National trends in treatment of type 2 diabetes mellitus, 1994–2007. Arch Intern Med 168(19):2088–2094
Alhowaish AK (2013) Economic costs of diabetes in Saudi Arabia. J Family Community Med 20(1):1–7
American Diabetes Association (2013a) Economic costs of diabetes in the U.S. in 2012. Diabetes Care 36(4):1033–1046
American Diabetes Association (2013b) Standards of medical care in diabetes. Diabetes Care 36(Suppl1):S11–S66
Arredondo A, Reyes G (2013) Health disparities from economic burden of diabetes in middle-income countries: evidence from México. PLoS One 8(7):e68443. doi:10.1371/journal.pone.0068443
Bahia LR, Araujo DV, Schaan BD et al (2011) The costs of type 2 diabetes mellitus outpatient care in the Brazilian public health system. Value Health 14(Suppl 1):S137–S140. doi:10.1016/j.jval.2011.05.009
Bertoldi AD, Kanavos P, França GV et al (2013) Epidemiology, management, complications and costs associated with type 2 diabetes in Brazil: a comprehensive literature review. Global Health 9:62. doi:10.1186/1744-8603-9-62
Caporale JE, Elgart JF, Gagliardino JJ (2013) Diabetes in Argentina: cost and management of diabetes and its complications and challenges for health policy. Global Health 9:54. doi:10.1186/1744-8603-9-54
Elgart JF, Caporale JE, Asteazaran S et al (2014) Association between socioeconomic status, type 2 diabetes and its chronic complications in Argentina. Diabetes Res Clin Pract 104(2):241–247
Ferrante D, Linetzky B, Konfino J et al (2011) Encuesta Nacional de Factores de Riesgo 2009: evolución de la epidemia de enfermedades crónicas no transmisibles en Argentina. Estudio de corte transversal. Rev Argent Salud Pública 2:34–41
Gagliardino JJ, Etchegoyen G et al (2001) A model educational program for people with type 2 diabetes: a cooperative Latin American implementation study (PEDNID-LA). Diabetes Care 24(6):1001–1007
Gagliardino JJ, Olivera E, Etchegoyen GS et al (2006) PROPAT: a study to improve the quality and reduce the cost of diabetes care. Diabetes Res Clin Pract 72(3):284–291
Gagliardino JJ, Aschner P, Baik SH et al (2012) Patients’ education and its impact on care outcomes, resource consumption and working conditions: data from the International Diabetes Management Practices Study (IDMPS). Diabetes Metab 38(2):128–134
Gagliardino JJ, Lapertosa S, Pfirter G et al (2013) Clinical, metabolic and psychological outcomes and treatment costs of a prospective randomized trial based on different educational strategies to improve diabetes care (PRODIACOR). Diabet Med 30(9):1102–1111
Hex N, Bartlett C, Wright D, Taylor M, Varley D (2012) Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabet Med 29(7):855–862
International Diabetes Federation (2010) Diabetes Social and Economic Impact Studies. http://www.idf.org/diabetes-social-and-economic-impact-studies/
International Diabetes Federation (2011) IDF Diabetes Atlas, Fifth Edition. Brussels: International Diabetes Federation. www.diabetesatlas.org
Jönsson B, CODE-2 Advisory Board (2002) Revealing the cost of Type II diabetes in Europe. Diabetologia 45(7):S5–S12
Le C, Lin L, Jun D et al (2013) The economic burden of type 2 diabetes mellitus in rural southwest China. Int J Cardiol 165(2):273–277
Leśniowska J, Schubert A, Wojna M, Skrzekowska-Baran I, Fedyna M (2014) Costs of diabetes and its complications in Poland. Eur J Health Econ 15(6):653–660
Rice DP (1967) Estimating the cost of illness. Am J Public Health Nations Health 13(3):424–440
Trento M, Gamba S, Gentile L et al (2010) Rethink organization to iMprove education and outcomes (ROMEO): a multicenter randomized trial of lifestyle intervention by group care to manage type 2 diabetes. Diabetes Care 33(4):745–747
Tunceli K, Bradley CJ, Nerenz D, Williams LK, Pladevall M, Elston Lafata J (2005) The impact of diabetes on employment and work productivity. Diabetes Care 28(11):2662–2667
Williams R, Van Gaal L, Lucioni C, CODE-2 Advisory Board (2002) Assessing the impact of complications on the costs of Type II diabetes. Diabetologia 45(7):S13–S17
World Health Organization (2008) International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10) version: 2008. http://www.who.int/classifications/icd/en/
Yang W, Zhao W, Xiao J et al (2012) Medical care and payment for diabetes in China: enormous threat and great opportunity. PLoS One 7(9):e39513. doi:10.1371/journal.pone.0039513
Zhang P, Zhang X, Brown J et al (2010) Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract 87(3):293–301
Zhuo X, Zhang P, Hoerger TJ (2013) Lifetime direct medical costs of treating type 2 diabetes and diabetic complications. Am J Prev Med 45(3):253–261
Acknowledgments
This study was partially supported with an unrestricted grant provided by Novo Nordisk International. The authors thank the authorities at the Private Hospital—Córdoba Medical Center, Argentina, J.E. Caporale for his useful comments and suggestions, E. Rucci for informatic support, and A. Di Maggio for careful manuscript editing. JFE and JJG contributed to the research design, analyzed data and wrote and reviewed the manuscript. JLDF and CC participated in research design and data collection. SA participated in the analysis and interpretation of the data. JBB contributed to discussion and critically reviewed the manuscript.
Conflict of interest
The authors have no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Elgart, J.F., Asteazarán, S., De La Fuente, J.L. et al. Direct and indirect costs associated to type 2 diabetes and its complications measured in a social security institution of Argentina. Int J Public Health 59, 851–857 (2014). https://doi.org/10.1007/s00038-014-0604-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00038-014-0604-4